Anoth Maharjan

Anoth Maharjan

Auto-generated profile, based on publicly available information

Anoth Maharjan

Bio‐Evaluation Center Korea Research Institute of Bioscience and Biotechnology Cheongju Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2024 in Heliyon
Verified
Journal Article
Open access
AMAnoth Maharjan
Anoth Maharjan
Bala  Murali Krishna VasamsettiBala Murali Krishna Vasamsetti
Bala Murali Krishna Vasamsetti
Jung-Ho ParkJung-Ho Park
Jung-Ho Park
Capsaicin, the main bioactive compound in chili peppers, is widely known for its diverse pharmacological effects, including antioxidant, anti-inflammatory, and anticancer effects. Despite its therapeutic potential, the low yield of natural capsaicin and the challenges in producing it on a large-scale limit broader industrial and clinical applications. This review provides a comprehensive analysis of capsaicin's biosynthesis in plants, chemical and enzymatic synthesis methods, and recent advancements in green production technologies. In addition, innovative applications such as drug delivery systems using nanoencapsulation and micelles are being developed to improve the bioavailability and therapeutic efficacy of capsaicin. Key findings highlight the use of capsaicin in food preservation, packaging, and pharmaceutical formulations. Future research should prioritize the refinement of synthetic routes, innovative delivery technologies, and the development of sustainable industrial processes to fully exploit the therapeutic and commercial potential of capsaicin.

20 September 2023 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Open access
AMAnoth Maharjan
Anoth Maharjan
Jung-Ho ParkJung-Ho Park
Jung-Ho Park
Cell‐free protein synthesis (CFPS) system is an innovative technology with a wide range of potential applications that could challenge current thinking and provide solutions to environmental and health issues. CFPS system has been demonstrated to be a successful way of producing biomolecules in a variety of applications, including the biomedical industry. Although there are still obstacles to overcome, its ease of use, versatility, and capacity for integration with other technologies open the door for it to continue serving as a vital instrument in synthetic biology research and industry. In this review, we mainly focus on the cell‐free based platform for various product productions. Moreover, the challenges in the bio‐therapeutic aspect using cell‐free systems and their future prospective for the improvement and sustainability of the cell free systems.

3 July 2024 in Sustainable Energy & Fuels
Verified
Journal Article
Closed access
PDF file
AMAnoth Maharjan
Anoth Maharjan
MKMi-Reu Kim
Mi-Reu Kim
WCWonho Choi
Wonho Choi
HKHyoung-Chin Kim
Hyoung-Chin Kim
Jung-Ho ParkJung-Ho Park
Jung-Ho Park
Commercialization has been primarily responsible for the recent sharp rise seen in energy consumption, which has coincided with an increasing global population.

26 June 2025 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Open access
AMAnoth Maharjan
Anoth Maharjan
Beom Soo KimBeom Soo Kim
Beom Soo Kim
Astaxanthin, a high‐value carotenoid with potent antioxidant and anti‐inflammatory activities, is increasingly in demand in various industries. This study reports the successful enhancement of astaxanthin and zeaxanthin production in Paracoccus sp. LL1 through random mutagenesis using ethyl methanesulfonate (EMS). To induce genetic diversity, EMS mutagenesis was employed, followed by the selection of mutants that exhibited increased carotenoid production. The top‐performing mutants showed a significant 2.76‐fold increase in astaxanthin and a 10.14‐fold increase in zeaxanthin compared to the wild‐type strain when treated with the optimal EMS concentration of 0.5%. The effects of initial glucose concentration and inoculum size on astaxanthin and zeaxanthin production were evaluated, and production was higher when glucose was 2% and inoculum size was 10%. Our findings demonstrate the potential of Paracoccus sp. LL1 as a promising alternative to traditional astaxanthin‐producing organisms, such as Haematococcus pluvialis , offering advantages including faster growth, simpler cultivation requirements, and genetic tractability. This approach not only enhances carotenoid production but also highlights the novelty of using Paracoccus sp. LL1, a less‐explored strain, for high‐yield production of both astaxanthin and zeaxanthin. These results suggest that Paracoccus sp. LL1 could serve as an efficient platform for industrial‐scale carotenoid production through metabolic engineering and random mutagenesis, providing a viable alternative to current production systems.

23 June 2026 in Macromolecular Materials and Engineering
Verified
Journal Article
Open access
PDF file
AMAnoth Maharjan
Anoth Maharjan
MKMi‐Reu Kim
Mi‐Reu Kim
HKHyoseon Kim
Hyoseon Kim
JAJungoh Ahn
Jungoh Ahn
Jung-Ho ParkJung-Ho Park
Jung-Ho Park
Efficient hydrolysis of crystalline cellulose necessitates a coordinated approach to substrate targeting, depolymerization, and product conversion. In this study, we present a tri‐domain GH7‐CBM2a‐GH3 fusion architecture that facilitates intramolecular synergy among processive cellulose depolymerization, substrate binding, and oligosaccharide hydrolysis within a single modular enzyme. The covalent integration of cellobiohydrolase (GH7) and β‐glucosidase (GH3) via a CBM2a targeting domain enhances localized catalytic coordination at the cellulose surface, thereby improving binding to crystalline substrates and minimizing diffusional constraints. In comparison to individual or merely mixed enzymes, the fusion construct demonstrates enhanced hydrolytic activity and greater stability under operational conditions. This research establishes enforced domain integration as an effective strategy for optimizing interfacial catalysis and advancing the design of efficient biocatalysts for sustainable biomass conversion.